211例中晚期肺癌的临床疗效分析

本文总结了211例中晚期肺癌的临床治疗效果。按国际四级标准:1年内近期疗效,电化疗的CR、PR有效率为69.2%,中药组为52.5%,中西医结合组为85.3%,后者的疗效优于前两组,P<0.05;远期随访结果:上述三组的4年生存率分别为46.3%、40.0%、53.8%。临床分析表明,以中西医结合组的疗效为佳。

英文摘要:

211 cases of middle and late stage of lung cancers were treated. They were failed to response to other treatments, or not indicated for surgical, radio-or chemotherapy. The diameter of tumors was 3 to 13cm. Method of treatment: Electrochemical treatment (ECT group, 130 cases): needles was inserted into the cancer served as electrodes, the amount of electricity varied according to the size of tumors, usually 100 coulomb per 1 cm~3 of cancer; TCM group (40 cases): Chinese medicine named AC7851 was given. One course of treatment lasted two months of continuous medication; ECT-TCM group (41 cases): ECT and AC7851 were given simultaneously. According to international grading, the short term effective rate of ECT group was 69.2%; that of TCM group was 52.5%, and ECT-TCM group 85.3%. The difference between the effective rate of latter group and former two groups was significant, P<0.05. After 1 4 years of follow up, the 4 year survival rate of the 3 groups were 46.3%, 40.0% and 53.8% respectively. Above-mentioned results indicated that the combined ECT-TCM therapy is the most effective treatment.

关闭